Paxlovid loses luster in people who aren't at high risk from Covid-19, Pfizer study finds

The antiviral medication Paxlovid appears to be most effective in people whose age or underlying health puts them at high risk for becoming severely ill with Covid-19, but it appears to be less effective for average-risk adults, drugmaker Pfizer reported.